3,813 companies
10,015 AI summaries
7,617 risk analyses
3,719 growth scores
Register free — watchlist & alerts →
🔔 Get free email alerts on Delta-Fly Pharma, Inc. (4598)
AI summaries of Japanese EDINET filings — in English. Free, unsubscribe anytime.
- ✓ Email alert when 4598 files its next EDINET disclosure
- ✓ AI summary · sentiment · risk · growth (JA / EN)
- ✓ Free account: watchlist & alerts on all the stocks you follow
EDINET 4598 Out of Scope
Delta-Fly Pharma, Inc.
Change Report ／ 2026-09-16 10:36
Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).
📊 Large-shareholding (5%) report Pure investment
Holder: Evo Fund
Stake: 22.71%
Change: -9.4pp decrease
Purpose:
Pure investment. While no specific circumstances are anticipated, the first filer may provide appropriate advice to the issuer from time to time as situations warrant.
🧩 5% holders of this company (5 holders · 44.38%)
| Holder | Stake | Change | |
|---|---|---|---|
| Evo Fund Pure | 20.65% | -2.06pp | view |
| SBI SECURITIES Co., Ltd. | 8.45% | new | view |
| Individual (江島 淸) Activist | 6.18% | -2.88pp | view |
| Arcus Investment Activist | 5.20% | new | view |
| Morgan Stanley | 3.90% | -1.54pp | view |
| Macquarie Bank Pure | 0.00% (exited) | -9.69pp | view |
Each holder’s most recent 5% filing. The sum reflects disclosed major-holder ownership, not total float.
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
Track Japanese disclosures with JSIGNAL
AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.
Start free — 30-day trial Login